HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.

8th Edition of Cardiology World Conference

September 27-29, 2027 | London, UK

September 27 -29, 2027 | London, UK

Angiotensin Receptor Blockers

Angiotensin Receptor Blockers

Angiotensin Receptor Blockers (ARBs) play a crucial role in the field of cardiovascular medicine by targeting the renin-angiotensin-aldosterone system. These medications, also known as angiotensin II receptor antagonists, work by blocking the action of angiotensin II on specific receptors, thereby dilating blood vessels and reducing the workload on the heart. ARBs are commonly prescribed to manage conditions such as hypertension, heart failure, and diabetic nephropathy. By modulating the effects of angiotensin II, ARBs contribute to blood pressure regulation and the overall well-being of individuals with cardiovascular concerns. Their distinct mechanism of action and efficacy make ARBs a valuable class of drugs in the therapeutic arsenal against cardiovascular diseases, offering patients a targeted and effective approach to managing their health.

Committee Members
Speaker at Cardiology World Conference 2027 - Sekib Sokolovic

Sekib Sokolovic

ASA Hospital, Bosnia and Herzegowina
Speaker at Cardiology World Conference 2027 - James V Cireddu

James V Cireddu

Case Western University, United States
Speaker at Cardiology World Conference 2027 - Iris Panagiota Efthymiou

Iris Panagiota Efthymiou

Regent College London, United Kingdom
Tags

Submit your abstract Today

Whatsapp